 | • レポートコード：GIR201114921 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、精密がん検査の世界市場を調査対象にし、精密がん検査の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（イメージング、体外診断、その他）、用途別分析（がん研究センター、がん病院、外科センター、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbott、Myriad Genetics、Cynvenio Biosystems、BD、Illumina、Bio-Rad、QIAGEN、Genomic Health、Foundation Medicine、NanoString Technologies、Randox Laboratories、Thermo Fisher Scientific、Roche、Philips ・企業別売上、市場シェア ・精密がん検査の地域別市場分析 ・精密がん検査の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・精密がん検査のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・精密がん検査のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・精密がん検査の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・精密がん検査の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・精密がん検査の種類別市場規模2015-2020：イメージング、体外診断、その他 ・精密がん検査の用途別市場規模2015-2020：がん研究センター、がん病院、外科センター、クリニック、その他 ・精密がん検査の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Precision Cancer Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Precision Cancer Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Precision Cancer Tests market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Precision Cancer Tests market has been segmented into:
Imaging
In Vitro Diagnostic
Others
By Application, Precision Cancer Tests has been segmented into:
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Precision Cancer Tests market presented in the report. This section sheds light on the sales growth of different regional and country-level Precision Cancer Tests markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Precision Cancer Tests market.
The report offers in-depth assessment of the growth and other aspects of the Precision Cancer Tests market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Precision Cancer Tests Market Share Analysis
Precision Cancer Tests competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Precision Cancer Tests sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Precision Cancer Tests sales, revenue and market share for each player covered in this report.
The major players covered in Precision Cancer Tests are:
Abbott
Myriad Genetics
Cynvenio Biosystems
BD
Illumina
Bio-Rad
QIAGEN
Genomic Health
Foundation Medicine
NanoString Technologies
Randox Laboratories
Thermo Fisher Scientific
Roche
Philips
1 Precision Cancer Tests Market Overview
1.1 Product Overview and Scope of Precision Cancer Tests
1.2 Classification of Precision Cancer Tests by Type
1.2.1 Global Precision Cancer Tests Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Precision Cancer Tests Revenue Market Share by Type in 2019
1.2.3 Imaging
1.2.4 In Vitro Diagnostic
1.2.5 Others
1.3 Global Precision Cancer Tests Market by Application
1.3.1 Overview: Global Precision Cancer Tests Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.3.6 Others
1.4 Global Precision Cancer Tests Market by Regions
1.4.1 Global Precision Cancer Tests Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Precision Cancer Tests (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Precision Cancer Tests Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Precision Cancer Tests Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Precision Cancer Tests Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Precision Cancer Tests Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Precision Cancer Tests Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.2 Myriad Genetics
2.2.1 Myriad Genetics Details
2.2.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Myriad Genetics SWOT Analysis
2.2.4 Myriad Genetics Product and Services
2.2.5 Myriad Genetics Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cynvenio Biosystems
2.3.1 Cynvenio Biosystems Details
2.3.2 Cynvenio Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cynvenio Biosystems SWOT Analysis
2.3.4 Cynvenio Biosystems Product and Services
2.3.5 Cynvenio Biosystems Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BD SWOT Analysis
2.4.4 BD Product and Services
2.4.5 BD Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Illumina SWOT Analysis
2.5.4 Illumina Product and Services
2.5.5 Illumina Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Rad SWOT Analysis
2.6.4 Bio-Rad Product and Services
2.6.5 Bio-Rad Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 QIAGEN SWOT Analysis
2.7.4 QIAGEN Product and Services
2.7.5 QIAGEN Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genomic Health
2.8.1 Genomic Health Details
2.8.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genomic Health SWOT Analysis
2.8.4 Genomic Health Product and Services
2.8.5 Genomic Health Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.9 Foundation Medicine
2.9.1 Foundation Medicine Details
2.9.2 Foundation Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Foundation Medicine SWOT Analysis
2.9.4 Foundation Medicine Product and Services
2.9.5 Foundation Medicine Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.10 NanoString Technologies
2.10.1 NanoString Technologies Details
2.10.2 NanoString Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 NanoString Technologies SWOT Analysis
2.10.4 NanoString Technologies Product and Services
2.10.5 NanoString Technologies Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.11 Randox Laboratories
2.11.1 Randox Laboratories Details
2.11.2 Randox Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Randox Laboratories SWOT Analysis
2.11.4 Randox Laboratories Product and Services
2.11.5 Randox Laboratories Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.12 Thermo Fisher Scientific
2.12.1 Thermo Fisher Scientific Details
2.12.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Thermo Fisher Scientific SWOT Analysis
2.12.4 Thermo Fisher Scientific Product and Services
2.12.5 Thermo Fisher Scientific Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.13 Roche
2.13.1 Roche Details
2.13.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Roche SWOT Analysis
2.13.4 Roche Product and Services
2.13.5 Roche Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
2.14 Philips
2.14.1 Philips Details
2.14.2 Philips Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Philips SWOT Analysis
2.14.4 Philips Product and Services
2.14.5 Philips Precision Cancer Tests Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Precision Cancer Tests Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Precision Cancer Tests Players Market Share
3.2.2 Top 10 Precision Cancer Tests Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Precision Cancer Tests Revenue and Market Share by Regions
4.2 North America Precision Cancer Tests Revenue and Growth Rate (2015-2020)
4.3 Europe Precision Cancer Tests Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Precision Cancer Tests Revenue and Growth Rate (2015-2020)
4.5 South America Precision Cancer Tests Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Precision Cancer Tests Revenue and Growth Rate (2015-2020)
5 North America Precision Cancer Tests Revenue by Countries
5.1 North America Precision Cancer Tests Revenue by Countries (2015-2020)
5.2 USA Precision Cancer Tests Revenue and Growth Rate (2015-2020)
5.3 Canada Precision Cancer Tests Revenue and Growth Rate (2015-2020)
5.4 Mexico Precision Cancer Tests Revenue and Growth Rate (2015-2020)
6 Europe Precision Cancer Tests Revenue by Countries
6.1 Europe Precision Cancer Tests Revenue by Countries (2015-2020)
6.2 Germany Precision Cancer Tests Revenue and Growth Rate (2015-2020)
6.3 UK Precision Cancer Tests Revenue and Growth Rate (2015-2020)
6.4 France Precision Cancer Tests Revenue and Growth Rate (2015-2020)
6.5 Russia Precision Cancer Tests Revenue and Growth Rate (2015-2020)
6.6 Italy Precision Cancer Tests Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Precision Cancer Tests Revenue by Countries
7.1 Asia-Pacific Precision Cancer Tests Revenue by Countries (2015-2020)
7.2 China Precision Cancer Tests Revenue and Growth Rate (2015-2020)
7.3 Japan Precision Cancer Tests Revenue and Growth Rate (2015-2020)
7.4 Korea Precision Cancer Tests Revenue and Growth Rate (2015-2020)
7.5 India Precision Cancer Tests Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Precision Cancer Tests Revenue and Growth Rate (2015-2020)
8 South America Precision Cancer Tests Revenue by Countries
8.1 South America Precision Cancer Tests Revenue by Countries (2015-2020)
8.2 Brazil Precision Cancer Tests Revenue and Growth Rate (2015-2020)
8.3 Argentina Precision Cancer Tests Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Precision Cancer Tests by Countries
9.1 Middle East & Africa Precision Cancer Tests Revenue by Countries (2015-2020)
9.2 Saudi Arabia Precision Cancer Tests Revenue and Growth Rate (2015-2020)
9.3 UAE Precision Cancer Tests Revenue and Growth Rate (2015-2020)
9.4 Egypt Precision Cancer Tests Revenue and Growth Rate (2015-2020)
9.5 South Africa Precision Cancer Tests Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Precision Cancer Tests Revenue and Market Share by Type (2015-2020)
10.2 Global Precision Cancer Tests Market Forecast by Type (2019-2024)
10.3 Imaging Revenue Growth Rate (2015-2025)
10.4 In Vitro Diagnostic Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Precision Cancer Tests Market Segment by Application
11.1 Global Precision Cancer Tests Revenue Market Share by Application (2015-2020)
11.2 Precision Cancer Tests Market Forecast by Application (2019-2024)
11.3 Cancer Research Centers Revenue Growth (2015-2020)
11.4 Cancer Hospital Revenue Growth (2015-2020)
11.5 Surgical Centers Revenue Growth (2015-2020)
11.6 Clinics Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Precision Cancer Tests Market Size Forecast (2021-2025)
12.1 Global Precision Cancer Tests Market Size Forecast (2021-2025)
12.2 Global Precision Cancer Tests Market Forecast by Regions (2021-2025)
12.3 North America Precision Cancer Tests Revenue Market Forecast (2021-2025)
12.4 Europe Precision Cancer Tests Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Precision Cancer Tests Revenue Market Forecast (2021-2025)
12.6 South America Precision Cancer Tests Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Precision Cancer Tests Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Precision Cancer Tests Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Precision Cancer Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Precision Cancer Tests Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Precision Cancer Tests Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Precision Cancer Tests Major Business
Table 7. Abbott Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Precision Cancer Tests Product and Solutions
Table 10. Abbott Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Myriad Genetics Corporate Information, Location and Competitors
Table 12. Myriad Genetics Precision Cancer Tests Major Business
Table 13. Myriad Genetics Precision Cancer Tests Total Revenue (USD Million) (2018-2019)
Table 14. Myriad Genetics SWOT Analysis
Table 15. Myriad Genetics Precision Cancer Tests Product and Solutions
Table 16. Myriad Genetics Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Cynvenio Biosystems Corporate Information, Location and Competitors
Table 18. Cynvenio Biosystems Precision Cancer Tests Major Business
Table 19. Cynvenio Biosystems Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 20. Cynvenio Biosystems SWOT Analysis
Table 21. Cynvenio Biosystems Precision Cancer Tests Product and Solutions
Table 22. Cynvenio Biosystems Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BD Corporate Information, Location and Competitors
Table 24. BD Precision Cancer Tests Major Business
Table 25. BD Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 26. BD SWOT Analysis
Table 27. BD Precision Cancer Tests Product and Solutions
Table 28. BD Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Illumina Corporate Information, Location and Competitors
Table 30. Illumina Precision Cancer Tests Major Business
Table 31. Illumina Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 32. Illumina SWOT Analysis
Table 33. Illumina Precision Cancer Tests Product and Solutions
Table 34. Illumina Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bio-Rad Corporate Information, Location and Competitors
Table 36. Bio-Rad Precision Cancer Tests Major Business
Table 37. Bio-Rad Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 38. Bio-Rad SWOT Analysis
Table 39. Bio-Rad Precision Cancer Tests Product and Solutions
Table 40. Bio-Rad Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. QIAGEN Corporate Information, Location and Competitors
Table 42. QIAGEN Precision Cancer Tests Major Business
Table 43. QIAGEN Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 44. QIAGEN SWOT Analysis
Table 45. QIAGEN Precision Cancer Tests Product and Solutions
Table 46. QIAGEN Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Genomic Health Corporate Information, Location and Competitors
Table 48. Genomic Health Precision Cancer Tests Major Business
Table 49. Genomic Health Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 50. Genomic Health SWOT Analysis
Table 51. Genomic Health Precision Cancer Tests Product and Solutions
Table 52. Genomic Health Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Foundation Medicine Corporate Information, Location and Competitors
Table 54. Foundation Medicine Precision Cancer Tests Major Business
Table 55. Foundation Medicine Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 56. Foundation Medicine SWOT Analysis
Table 57. Foundation Medicine Precision Cancer Tests Product and Solutions
Table 58. Foundation Medicine Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. NanoString Technologies Corporate Information, Location and Competitors
Table 60. NanoString Technologies Precision Cancer Tests Major Business
Table 61. NanoString Technologies Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 62. NanoString Technologies SWOT Analysis
Table 63. NanoString Technologies Precision Cancer Tests Product and Solutions
Table 64. NanoString Technologies Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Randox Laboratories Corporate Information, Location and Competitors
Table 66. Randox Laboratories Precision Cancer Tests Major Business
Table 67. Randox Laboratories Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 68. Randox Laboratories SWOT Analysis
Table 69. Randox Laboratories Precision Cancer Tests Product and Solutions
Table 70. Randox Laboratories Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 72. Thermo Fisher Scientific Precision Cancer Tests Major Business
Table 73. Thermo Fisher Scientific Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 74. Thermo Fisher Scientific SWOT Analysis
Table 75. Thermo Fisher Scientific Precision Cancer Tests Product and Solutions
Table 76. Thermo Fisher Scientific Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Roche Corporate Information, Location and Competitors
Table 78. Roche Precision Cancer Tests Major Business
Table 79. Roche Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 80. Roche SWOT Analysis
Table 81. Roche Precision Cancer Tests Product and Solutions
Table 82. Roche Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Philips Corporate Information, Location and Competitors
Table 84. Philips Precision Cancer Tests Major Business
Table 85. Philips Precision Cancer Tests Total Revenue (USD Million) (2017-2018)
Table 86. Philips SWOT Analysis
Table 87. Philips Precision Cancer Tests Product and Solutions
Table 88. Philips Precision Cancer Tests Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Precision Cancer Tests Revenue (Million USD) by Players (2015-2020)
Table 90. Global Precision Cancer Tests Revenue Share by Players (2015-2020)
Table 91. Global Precision Cancer Tests Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Precision Cancer Tests Revenue Market Share by Regions (2015-2020)
Table 93. North America Precision Cancer Tests Revenue by Countries (2015-2020)
Table 94. North America Precision Cancer Tests Revenue Market Share by Countries (2015-2020)
Table 95. Europe Precision Cancer Tests Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Precision Cancer Tests Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Precision Cancer Tests Revenue by Countries (2015-2020)
Table 98. South America Precision Cancer Tests Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Precision Cancer Tests Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Precision Cancer Tests Revenue Market Share by Countries (2015-2020)
Table 101. Global Precision Cancer Tests Revenue (Million USD) by Type (2015-2020)
Table 102. Global Precision Cancer Tests Revenue Share by Type (2015-2020)
Table 103. Global Precision Cancer Tests Revenue Forecast by Type (2021-2025)
Table 104. Global Precision Cancer Tests Revenue by Application (2015-2020)
Table 105. Global Precision Cancer Tests Revenue Share by Application (2015-2020)
Table 106. Global Precision Cancer Tests Revenue Forecast by Application (2021-2025)
Table 107. Global Precision Cancer Tests Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Precision Cancer Tests Picture
Figure 2. Global Precision Cancer Tests Revenue Market Share by Type in 2019
Figure 3. Imaging Picture
Figure 4. In Vitro Diagnostic Picture
Figure 5. Others Picture
Figure 6. Precision Cancer Tests Revenue Market Share by Application in 2019
Figure 7. Cancer Research Centers Picture
Figure 8. Cancer Hospital Picture
Figure 9. Surgical Centers Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Precision Cancer Tests Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Precision Cancer Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Precision Cancer Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Precision Cancer Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Precision Cancer Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Precision Cancer Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Precision Cancer Tests Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Precision Cancer Tests Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Precision Cancer Tests Revenue Market Share in 2019
Figure 21. Global Top 10 Players Precision Cancer Tests Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Precision Cancer Tests Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Precision Cancer Tests Revenue Market Share by Regions (2015-2020)
Figure 25. Global Precision Cancer Tests Revenue Market Share by Regions in 2018
Figure 26. North America Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 27. Europe Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 29. South America Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 31. North America Precision Cancer Tests Revenue Market Share by Countries (2015-2020)
Figure 32. North America Precision Cancer Tests Revenue Market Share by Countries in 2019
Figure 33. USA Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 34. Canada Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 36. Europe Precision Cancer Tests Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Precision Cancer Tests Revenue Market Share by Countries in 2019
Figure 38. Germany Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 39. UK Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 40. France Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 41. Russia Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 42. Italy Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Precision Cancer Tests Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Precision Cancer Tests Revenue Market Share by Countries in 2019
Figure 45. China Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 46. Japan Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 47. Korea Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 48. India Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 50. South America Precision Cancer Tests Revenue Market Share by Countries (2015-2020)
Figure 51. South America Precision Cancer Tests Revenue Market Share by Countries in 2019
Figure 52. Brazil Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Precision Cancer Tests Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Precision Cancer Tests Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 57. UAE Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Precision Cancer Tests Revenue and Growth Rate (2015-2020)
Figure 60. Global Precision Cancer Tests Revenue Share by Type (2015-2020)
Figure 61. Global Precision Cancer Tests Revenue Share by Type in 2019
Figure 62. Global Precision Cancer Tests Market Share Forecast by Type (2021-2025)
Figure 63. Global Imaging Revenue Growth Rate (2015-2020)
Figure 64. Global In Vitro Diagnostic Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Precision Cancer Tests Revenue Share by Application (2015-2020)
Figure 67. Global Precision Cancer Tests Revenue Share by Application in 2019
Figure 68. Global Precision Cancer Tests Market Share Forecast by Application (2021-2025)
Figure 69. Global Cancer Research Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Cancer Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Surgical Centers Revenue Growth Rate (2015-2020)
Figure 72. Global Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Precision Cancer Tests Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Precision Cancer Tests Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Precision Cancer Tests Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Precision Cancer Tests Revenue Market Forecast (2021-2025)
Figure 78. Europe Precision Cancer Tests Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Precision Cancer Tests Revenue Market Forecast (2021-2025)
Figure 80. South America Precision Cancer Tests Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Precision Cancer Tests Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
体外大腸がんスクリーニング検査の世界市場 2020年 Market Overview The global In-Vitro Colorectal Cancer Screening Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1185 million by 2025, from USD 964.8 million in 2019. …- B型肝炎診断テストの世界市場 2020年 Market Overview The global Hepatitis B Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis B Diag…
- 肝炎ウイルス診断テストの世界市場 2020年 Market Overview The global Hepatitis Viruses Diagnostic Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis …
- オイルコンディション試験の世界市場 2020年 Market Overview The global Oil Condition Tests market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oil Condition Tests marke…
- 腫瘍バイオマーカー検査の世界市場 2020年 Market Overview The global Tumor Biomarker Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Biomarker Test mar…